Literature DB >> 24444319

Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies.

Tarek K Rajji1, Dielle Miranda2, Benoit H Mulsant3.   

Abstract

This paper aims to review longitudinal studies assessing the impact of cognition on function in patients with schizophrenia. PubMed and Scholars Portal were searched using search terms related to schizophrenia, cognition, function, and longitudinal studies. Some functional abilities have been studied more than others. Some studies suggest that the impact of cognition on function depends on the severity of baseline cognitive deficits. Other studies suggest that the impact of cognition on function depend on what phase of the illness the patient is in or what stage in that particular function the patient is involved in. Finally, few studies assessed interactions between cognition and other aspects of schizophrenia in predicting function, such as functional capacity, insight, motivation, and negative symptoms. More longitudinal and comprehensive studies are needed. A focus on community living is of high public significance as patients with schizophrenia continue to grow old. Future studies should also focus on the longitudinal interactions between cognition and other dimensions of schizophrenia as well as on the biological factors that underlie these interactions.

Entities:  

Keywords:  cognition; disability; function; rehabilitation; schizophrenia

Mesh:

Year:  2014        PMID: 24444319      PMCID: PMC4079219          DOI: 10.1177/070674371405900104

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  55 in total

1.  Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study.

Authors:  J Addington; D Addington
Journal:  Schizophr Res       Date:  2000-07-07       Impact factor: 4.939

2.  Symptoms and cognition as predictors of community functioning: a prospective analysis.

Authors:  R M Norman; A K Malla; L Cortese; S Cheng; K Diaz; E McIntosh; T S McLean; A Rickwood; L P Voruganti
Journal:  Am J Psychiatry       Date:  1999-03       Impact factor: 18.112

3.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

4.  Basic neuropsychological dimensions in schizophrenia.

Authors:  Judith Jaeger; Pál Czobor; Stefanie M Berns
Journal:  Schizophr Res       Date:  2003-12-15       Impact factor: 4.939

Review 5.  The role of motivation for treatment success.

Authors:  Alice Medalia; Alice Saperstein
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

6.  Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients.

Authors:  J W Kasckow; E Twamley; J J Mulchahey; B Carroll; M Sabai; S M Strakowski; T Patterson; D V Jeste
Journal:  Psychiatry Res       Date:  2001-08-05       Impact factor: 3.222

7.  Neurocognitive predictors of work outcome in recent-onset schizophrenia.

Authors:  Keith H Nuechterlein; Kenneth L Subotnik; Michael F Green; Joseph Ventura; Robert F Asarnow; Michael J Gitlin; Cindy M Yee; Denise Gretchen-Doorly; Jim Mintz
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

8.  Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.

Authors:  J I Friedman; P D Harvey; T Coleman; P J Moriarty; C Bowie; M Parrella; L White; D Adler; K L Davis
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

Review 9.  Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature.

Authors:  Vasilis P Bozikas; Christina Andreou
Journal:  Aust N Z J Psychiatry       Date:  2011-02       Impact factor: 5.744

Review 10.  The role of cognitive functioning in the outcome of those at clinical high risk for developing psychosis.

Authors:  J Addington; M Barbato
Journal:  Epidemiol Psychiatr Sci       Date:  2012-12       Impact factor: 6.892

View more
  31 in total

1.  Re: Cognition in schizophrenia.

Authors:  François Mai
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

2.  Intrinsic Connectivity of the Globus Pallidus: An Uncharted Marker of Functional Prognosis in People With First-Episode Schizophrenia.

Authors:  Goda Tarcijonas; William Foran; Gretchen L Haas; Beatriz Luna; Deepak K Sarpal
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

3.  Assessment of functioning and disability in patients with schizophrenia using the WHO Disability Assessment Schedule 2.0 in a large-scale database.

Authors:  Ruey Chen; Tsan-Hon Liou; Kwang-Hwa Chang; Chia-Feng Yen; Hua-Fang Liao; Wen-Chou Chi; Kuei-Ru Chou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-11       Impact factor: 5.270

4.  The role of cognition in outcome in schizophrenia and related disorders.

Authors:  Ashok Malla
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

5.  The role of vulnerability factors in individuals with an at-risk mental state of psychosis.

Authors:  Martina Papmeyer; Irène Würsch; Erich Studerus; Rolf-Dieter Stieglitz; Anita Riecher-Rössler
Journal:  Neuropsychiatr       Date:  2016-03-11

6.  Postnatal Administration of Dizocilpine Inhibits Neuronal Excitability in PFC and Induces Social Deficits Detected by MiceProfiler.

Authors:  Dexiao Zhu; Hui Wang; Jintao Wu; Qian Wang; Ling Xu; Yue Zhao; Kunkun Pang; Qingqing Shi; Wenbo Zhao; Jing Zhang; Jinhao Sun
Journal:  Mol Neurobiol       Date:  2016-11-28       Impact factor: 5.590

Review 7.  Converging models of schizophrenia--Network alterations of prefrontal cortex underlying cognitive impairments.

Authors:  Takeshi Sakurai; Nao J Gamo; Takatoshi Hikida; Sun-Hong Kim; Toshiya Murai; Toshifumi Tomoda; Akira Sawa
Journal:  Prog Neurobiol       Date:  2015-09-25       Impact factor: 11.685

8.  Paliperidone Protects SH-SY5Y Cells Against MK-801-Induced Neuronal Damage Through Inhibition of Ca(2+) Influx and Regulation of SIRT1/miR-134 Signal Pathway.

Authors:  Dexiao Zhu; Jing Zhang; Jintao Wu; Guibao Li; Wei Yao; Jing Hao; Jinhao Sun
Journal:  Mol Neurobiol       Date:  2015-06-09       Impact factor: 5.590

9.  Proxy measures of premortem cognitive aptitude in postmortem subjects with schizophrenia.

Authors:  Jill R Glausier; Mary Ann Kelly; Samantha Salem; Kehui Chen; David A Lewis
Journal:  Psychol Med       Date:  2019-03-14       Impact factor: 7.723

10.  Effectiveness of Community Occupational Therapy Intervention in, with and from the Community in People with Disabilities in Azrou (Morocco).

Authors:  Jerónimo J González-Bernal; Leire Eiguren-Munitis; Josefa González-Santos; Mirian Santamaría-Peláez; Raúl Soto-Cámara; Paula Rodríguez-Fernández
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.